biote Corp. announced that the management expects 2023 revenue to be slightly below prior guidance. The Company had previously forecast that revenue would be toward the lower end of the previously announced ranges of $190 million-$200 million.

The Company now expects full year 2023 revenue of $185 million-$187 million. The Company?s expected 2023 revenue growth of approximately 12% over the prior year includes procedure revenue growth of approximately 9% and dietary supplement revenue growth of approximately 17%, as compared to the prior year.